Progress in the clinical application of cord blood transfusion in neonates.
10.7499/j.issn.1008-8830.2409146
- Author:
Yue HAN
1
Author Information
1. Department of Neonatology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.
- Publication Type:English Abstract
- Keywords:
Anemia;
Cord blood;
Neonate;
Transfusion
- MeSH:
Humans;
Infant, Newborn;
Fetal Blood;
Blood Transfusion
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(4):487-492
- CountryChina
- Language:Chinese
-
Abstract:
The primary source of blood transfusions for neonates is allogeneic adult blood. While allogeneic adult blood can provide timely and effective transfusion support for neonates, there are differences in hemoglobin types and coagulation systems between adults and neonates, along with potential infection risks. In recent years, the clinical value of cord blood transfusion in early surgical interventions and anemia management for neonates has been increasingly recognized. Studies have shown that cord blood transfusion not only reduces the incidence of complications in preterm infants but also provides a safer alternative transfusion source for neonates. However, cord blood transfusion has not yet been widely adopted. This article reviews the advantages, clinical application progress, and significance of cord blood transfusion in neonates, to provide evidence supporting its broader clinical implementation.
